Skip to main content

Table 1 Pretherapeutic patients’ characteristics

From: Association of angiogenic factors with prognosis in esophageal cancer

Characteristics   n % Median survival (IQR) 95%CI 3-Y-S (%) p value
Total, n   78 100,0% 28,5 (13,7;*)   42,7%  
Age (years) 63 ± 7,8 (41–80)       
Sex Male 62 79,5% 28,5 (13,8;*) 16,1 - 40,9 42,6% 0,711
  Female 16 20,5% 29,1 (11,6;*) - 45,6%  
Localisation AEG I/II 44 56,4% 28,5 (17,0;*) 19,2 - 37,8 37,7% 0,904
  SCC 34 43,6% n.r. - 50,9%  
cT Category cT1 0      
  cT2 5 6,4% n.r. - 60,0% 0,812
  cT3 69 88,5% 23,8 (12,8;*) 15,9 - 31,7 42,8%  
  cT4 4 5,1% 36,7 (33,7;*) 31,9 - 41,5 33,3%  
cN Category cN0 17 21,8% 30,6 (20,5;*) 15,5 - 45,7 37,8% 0,906
  cN+ 61 78,2% 24,0 (12,3;*) 9,1 - 38,8 44,6%  
cM Category cM0 67 85,9% 23,8 (12,8;*) 15,1 - 32,5 40,2% 0,317
  cM1 11 14,1% n.r. - 57,3%  
Grading G 1/2 32 41,0% 23,1 (11,0;*) 13,4 - 32,7 34,0% 0,428
  G 3/4 38 48,7% 29,1 (13,8;*) - 45,5%  
Lauren initial (AEG) Intestinal 26 59,1% 30,6 (17,0;*) 15,6 - 45,6 40,4% 0,620
  Nonintestinal 13 29,5% 24,0 (20,3;*) 19,3 - 28,6 33,8%  
  1. Median Survival shown in months; n.r.: not reached; CI: confidence interval; 3-Y-S: 3-Year-Survival; IQR: inter quartile range (1st quartile; 3rd quartile (* 3rd quartile not reached)).